Change - Announcement of Appointment::Appointment of Deputy Chairman

Issuer & Securities

Issuer/ Manager
MEDTECS INTERNATIONAL CORP LTD
Securities
MEDTECS INTERNATIONAL CORP LTD - BMG5958R1043 - 546
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Appointment
Date &Time of Broadcast
10-Mar-2021 18:02:16
Status
New
Announcement Sub Title
Appointment of Deputy Chairman
Announcement Reference
SG210310OTHRNTAC
Submitted By (Co./ Ind. Name)
Clement Yang Ker-Cheng
Designation
Executive Chairman
Description (Please provide a detailed description of the event in the box below)
Mr William Yang Weiyuan ("Mr Yang") replaced Mr Wilfrido Candelaria Rodriguez as Deputy Chairman with effect from 26 February 2021. Mr Yang is the Chief Executive Officer, Executive Director and a member of the Nominating Committee of the Company.

This announcement has been prepared by the Company and its contents have been reviewed by the Company's sponsor, R & T Corporate Services Pte. Ltd. ("Sponsor"), for compliance with the relevant rules of the Singapore Exchange Securities Trading Limited ("Exchange"). The Sponsor has not independently verified the contents of this announcement including the accuracy or completeness of any of the figures used, statements, opinions or other information made or disclosed.

This announcement has not been examined or approved by the Exchange. The Exchange assumes no responsibility for the contents of this announcement including the correctness of any of the statements or opinions made or reports contained in this announcement.

The contact persons for the Sponsor are Ms Evelyn Wee (Tel no.: +65 6232 0724) and Mr Howard Cheam Heng Haw (Tel no.: +65 6232 0685), R & T Corporate Services Pte. Ltd., at 9 Straits View, Marina One West Tower, #06-07 Singapore 018937.

Additional Details

Date Of Appointment
26/02/2021
Name Of Person
William Yang Weiyuan
Age
38
Country Of Principal Residence
Taiwan, Province Of China
The Board's comments on this appointment (including rationale, selection criteria, and the search and nomination process)
Following Mr Wilfrido Candelaria Rodriguez's resignation as Deputy Chairman and Executive Director on 11 August 2020, the Company was required to appoint a Deputy Chairman in accordance with bye-law 126 of the Company's bye-laws. The Board has considered and accepted the recommendations of the management and the Nominating Committee to appoint Mr William Yang Weiyuan as the Company's Deputy Chairman and Executive Director, after reviewing his professional qualifications and work experience.
Whether appointment is executive, and if so, the area of responsibility
Executive. Mr William Yang Weiyuan will be responsible for the day-to-day operations as well as the development of business of the Group.
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Deputy Chairman, Chief Executive Officer and Executive Director.
Professional qualifications
New York Institute of Technology, Bachelor of Science, Electrical and Computer Engineering, 2005
Any relationship (including immediate family relationships) with any existing director, existing executive officer, the issuer and/ or substantial shareholder of the listed issuer or any of its principal subsidiaries
Son to Mr Clement Yang Ker-Cheng, Executive Chairman of the Company and Ms Sherry Chen Su-Tien, Non-Executive Chairman of Medtecs (Taiwan) Corporation, a principal subsidiary of the Company; brother to Ms Wan Chien Yang, the general counsel of Medtecs International Corporation Limited, a director of Medtecs USA Corporation and Medtecs MSEZ Corp Ltd (Cambodia), and a supervisor and director of Medtecs (Taiwan) Corporation.
Conflict of interests (including any competing business)
No conflict of interests.
Working experience and occupation(s) during the past 10 years
Chief Executive Officer, Medtecs International Corporation Limited (2018 to present)
Executive Director, Medtecs International Corporation Limited (2013 to present)
General Manager, Medtecs (Taiwan) Corporation (2010 to present)
General Manager, Hangzhou Jincheng Medical Supplies & Manufacture Co., Ltd (2008 to present)
General Manager, Shanghai Greenway Medical Apparatus (2006 to 2009)
Undertaking submitted to the listed issuer in the form of Appendix 7.7 (Listing Rule 704(7)) Or Appendix 7H (Catalist Rule 704(6))
Yes
Shareholding interest in the listed issuer and its subsidiaries?
Yes
Shareholding Details
1500000 shares (deemed interest)
# These fields are not applicable for announcements of appointments pursuant to Listing Rule 704 (9) or Catalist Rule 704 (8).
Past (for the last 5 years)
Nil.
Present
1. Medtecs Internatonal Corporation Limited
2. Medtecs (Taiwan) Corporation
3. Medtecs MSEZ Corp., Ltd
4. Cooper Development Ltd
5. Hangzhou Jincheng Medical Supplies & Manufacture Co., Ltd.
6. World Join International Ltd.
(a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner?
No
(b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency?
No
(c) Whether there is any unsatisfied judgment against him?
No
(d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose?
No
(e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach?
No
(f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part?
No
(g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust?
No
(h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust?
No
(i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity?
No
(j) Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :-
(i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or
No
(ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or
No
(iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or
No
(iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust?
No
(k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere?
No
Any prior experience as a director of an issuer listed on the Exchange?
Yes
If Yes, Please provide details of prior experience
Executive Director of the Company since 2 September 2013
Please provide details of relevant experience and the nominating committee's reasons for not requiring the director to undergo training as prescribed by the Exchange (if applicable)
Not applicable.